Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression

Christoph F A Vogel, Wen Li, Eric Sciullo, John Newman, Bruce Hammock, J. Rachel Reader, Joseph Tuscano, Fumio Matsumura

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Epidemiological studies indicate that exposure to environmental pollutants such as pesticides and dioxins leads to the pathogenesis of lymphoma and leukemia. Here, we show that activation of the aryl hydrocarbon receptor (AhR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in loss of the programmed cell death (apoptosis) response in three different lymphoma cell lines, which plays a key role in the development of cancer, especially lymphoma and leukemia. The AhR-mediated inhibition of apoptosis in vitro was associated with a clear increase of cyclooxygenase-2 (COX-2) and deregulation of genes of the B-cell lymphoma-2 (Bcl-2) family involved in apoptosis including Bcl-xl and Mcl-1 in several lymphoma cell lines. Treatment with the COX-2 inhibitor NS-398 and the AhR antagonist 3′-methoxy-4′-nitroflavone abolished the TCDD-induced resistance of apoptosis in vitro. Furthermore, using micropositron emission tomography imaging, in vivo findings demonstrated that exposure to TCDD promotes the development of lymphoma in superficial lymph nodes of C57BL/10J mice, which was associated with a marked increase of COX-2 expression in the affected lymph nodes. The results indicate that AhR activation and COX-2 overexpression likely represent a mechanism of resistance to apoptosis in lymphoma cell lines that might be relevant for the development of lymphoma in vivo.

Original languageEnglish (US)
Pages (from-to)1538-1548
Number of pages11
JournalAmerican Journal of Pathology
Volume171
Issue number5
DOIs
StatePublished - Nov 2007

Fingerprint

Aryl Hydrocarbon Receptors
Cyclooxygenase 2
Lymphoma
Apoptosis
Cell Line
Leukemia
Lymph Nodes
Environmental Pollutants
Dioxins
Cyclooxygenase 2 Inhibitors
B-Cell Lymphoma
Inbred C57BL Mouse
Pesticides
Epidemiologic Studies
Cell Death
Tomography
Genes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. / Vogel, Christoph F A; Li, Wen; Sciullo, Eric; Newman, John; Hammock, Bruce; Reader, J. Rachel; Tuscano, Joseph; Matsumura, Fumio.

In: American Journal of Pathology, Vol. 171, No. 5, 11.2007, p. 1538-1548.

Research output: Contribution to journalArticle

Vogel, Christoph F A ; Li, Wen ; Sciullo, Eric ; Newman, John ; Hammock, Bruce ; Reader, J. Rachel ; Tuscano, Joseph ; Matsumura, Fumio. / Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression. In: American Journal of Pathology. 2007 ; Vol. 171, No. 5. pp. 1538-1548.
@article{5c2dda8ab35644e8a722d8dae3eb612d,
title = "Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression",
abstract = "Epidemiological studies indicate that exposure to environmental pollutants such as pesticides and dioxins leads to the pathogenesis of lymphoma and leukemia. Here, we show that activation of the aryl hydrocarbon receptor (AhR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in loss of the programmed cell death (apoptosis) response in three different lymphoma cell lines, which plays a key role in the development of cancer, especially lymphoma and leukemia. The AhR-mediated inhibition of apoptosis in vitro was associated with a clear increase of cyclooxygenase-2 (COX-2) and deregulation of genes of the B-cell lymphoma-2 (Bcl-2) family involved in apoptosis including Bcl-xl and Mcl-1 in several lymphoma cell lines. Treatment with the COX-2 inhibitor NS-398 and the AhR antagonist 3′-methoxy-4′-nitroflavone abolished the TCDD-induced resistance of apoptosis in vitro. Furthermore, using micropositron emission tomography imaging, in vivo findings demonstrated that exposure to TCDD promotes the development of lymphoma in superficial lymph nodes of C57BL/10J mice, which was associated with a marked increase of COX-2 expression in the affected lymph nodes. The results indicate that AhR activation and COX-2 overexpression likely represent a mechanism of resistance to apoptosis in lymphoma cell lines that might be relevant for the development of lymphoma in vivo.",
author = "Vogel, {Christoph F A} and Wen Li and Eric Sciullo and John Newman and Bruce Hammock and Reader, {J. Rachel} and Joseph Tuscano and Fumio Matsumura",
year = "2007",
month = "11",
doi = "10.2353/ajpath.2007.070406",
language = "English (US)",
volume = "171",
pages = "1538--1548",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression

AU - Vogel, Christoph F A

AU - Li, Wen

AU - Sciullo, Eric

AU - Newman, John

AU - Hammock, Bruce

AU - Reader, J. Rachel

AU - Tuscano, Joseph

AU - Matsumura, Fumio

PY - 2007/11

Y1 - 2007/11

N2 - Epidemiological studies indicate that exposure to environmental pollutants such as pesticides and dioxins leads to the pathogenesis of lymphoma and leukemia. Here, we show that activation of the aryl hydrocarbon receptor (AhR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in loss of the programmed cell death (apoptosis) response in three different lymphoma cell lines, which plays a key role in the development of cancer, especially lymphoma and leukemia. The AhR-mediated inhibition of apoptosis in vitro was associated with a clear increase of cyclooxygenase-2 (COX-2) and deregulation of genes of the B-cell lymphoma-2 (Bcl-2) family involved in apoptosis including Bcl-xl and Mcl-1 in several lymphoma cell lines. Treatment with the COX-2 inhibitor NS-398 and the AhR antagonist 3′-methoxy-4′-nitroflavone abolished the TCDD-induced resistance of apoptosis in vitro. Furthermore, using micropositron emission tomography imaging, in vivo findings demonstrated that exposure to TCDD promotes the development of lymphoma in superficial lymph nodes of C57BL/10J mice, which was associated with a marked increase of COX-2 expression in the affected lymph nodes. The results indicate that AhR activation and COX-2 overexpression likely represent a mechanism of resistance to apoptosis in lymphoma cell lines that might be relevant for the development of lymphoma in vivo.

AB - Epidemiological studies indicate that exposure to environmental pollutants such as pesticides and dioxins leads to the pathogenesis of lymphoma and leukemia. Here, we show that activation of the aryl hydrocarbon receptor (AhR) by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in loss of the programmed cell death (apoptosis) response in three different lymphoma cell lines, which plays a key role in the development of cancer, especially lymphoma and leukemia. The AhR-mediated inhibition of apoptosis in vitro was associated with a clear increase of cyclooxygenase-2 (COX-2) and deregulation of genes of the B-cell lymphoma-2 (Bcl-2) family involved in apoptosis including Bcl-xl and Mcl-1 in several lymphoma cell lines. Treatment with the COX-2 inhibitor NS-398 and the AhR antagonist 3′-methoxy-4′-nitroflavone abolished the TCDD-induced resistance of apoptosis in vitro. Furthermore, using micropositron emission tomography imaging, in vivo findings demonstrated that exposure to TCDD promotes the development of lymphoma in superficial lymph nodes of C57BL/10J mice, which was associated with a marked increase of COX-2 expression in the affected lymph nodes. The results indicate that AhR activation and COX-2 overexpression likely represent a mechanism of resistance to apoptosis in lymphoma cell lines that might be relevant for the development of lymphoma in vivo.

UR - http://www.scopus.com/inward/record.url?scp=36348988444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36348988444&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2007.070406

DO - 10.2353/ajpath.2007.070406

M3 - Article

C2 - 17823287

AN - SCOPUS:36348988444

VL - 171

SP - 1538

EP - 1548

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -